Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States

Rohde, Luís Eduardo Paim; Clausell, Nadine Oliveira; Ribeiro, Jorge Pinto; Goldraich, Lívia Adams; Netto, Rafael; Dec, G. William; DiSalvo, Thomas G.; Polanczyk, Carísi Anne

doi:10.1016/j.ijcard.2004.04.006

Cited by 60 publications

(58 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The hospitalization time is longer than that reported in other studies [13][14][15] . It is described that, in general, patients are hospitalized for four to five days to compensate, when the HF condition is not severe, and around nine days for the most severe ones [13][14][15] .…”

Section: Discussioncontrasting

confidence: 54%

“…When analyzing the three groups, we observed that the patients remained hospitalized for about 13 days after discontinuation of inotropic. If we reduce those 13 days from the total hospitalization time, we can verify that the remaining time does not differ from those described in the Brazilian hospitals 12,14,15 .…”

Section: Discussionmentioning

confidence: 81%

“…It is described that, in general, patients are hospitalized for four to five days to compensate, when the HF condition is not severe, and around nine days for the most severe ones [13][14][15] . In Rio de Janeiro, for patients treated at the Emergency Room of a private institution, length of hospital stay was 9.5 days, and in Porto Alegre in a school hospital like ours, it was of 11 days, both times smaller than ours 14,15 . The highest severity of our cases may explain, in part, that long hospitalization time.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

É necessário suspender o betabloqueador na insuficiência cardíaca descompensada com baixo débito?

Lima¹,

Cardoso²,

Ochiai³

et al. 2010

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 54%

Section: Discussionmentioning

confidence: 81%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

É necessário suspender o betabloqueador na insuficiência cardíaca descompensada com baixo débito?

Lima¹,

Cardoso²,

Ochiai³

et al. 2010

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

“…Another interesting data regards the average age of the patients, which is lower than the average described in international literature, data that was also observed in HF decompensation. In the study comparing results from HF treatment among tertiary hospitals in Brazil and the United States (15) , Brazilians with HF also had lower average ages.…”

Section: Discussionmentioning

confidence: 99%

“…National and international studies (15,4) have evidenced the under-utilization of ACEI. Therefore, almost ten years after the indication of the use of ACEI, it can be verified that many patients still lack the benefits of using the two only drugs that, until now, are proven to change the course of HF evolution.…”

Section: Discussionmentioning

confidence: 99%

Características clínicas e psicossociais do paciente com insuficiência cardíaca que interna por descompensação clínica

Margoto¹,

Colombo

Gallani

2009

Rev. esc. enferm. USP

View full text Add to dashboard Cite

RESUMOEste estudo teve como objetivo identificar perfil sociodemográfico e clínico, história de hospitalizações por Insuficiência Cardí-aca (IC) e seguimento (consultas regulares, tratamento medicamentoso, fatores facilitadores e dificultadores do seguimento) do paciente internado por quadro de descompensação clínica. Foram entrevistados 61 pacientes com idade média de 58,1 (± 15,9) anos, 3,5 (± 4,4) anos de estudo e renda individual de 1,3 (± 2,4) salários-mínimos. A maioria dos sujeitos se encontrava em classe funcional III ou IV da New York Heart Association, tendo como causa mais freqüente de hospitalização, os sinais/sintomas da forma congestiva da IC. 75,4% dos sujeitos relataram acompanhamento clíni-co, porém de periodicidade irregular. Constatou-se utilização de terapêutica medicamentosa em proporção inferior à recomendada pela literatura. Os achados devem auxiliar a identificação dos pacientes com maior risco de descompensação da IC e assim, desenhar e implementar intervenções específicas visando a redução das re-hospitalizações por IC. DESCRITORESInsuficiência cardíaca. Cuidados de enfermagem. Hospitalização. Gláucia Margoto 1 , Roberta Cunha Rodrigues Colombo 2 , Maria Cecília Bueno Jayme Gallani 3 ABSTRACTThis study had the purpose to identify the sociodemographic and clinical profiles, history of hospitalizations due to Heart Failure (HF) and follow-ups (regular appointments, drug treatment, facilities and difficulties for follow-up) of patients admitted for clinical decompensation. Interviews were held with 61 patients, with average age of 58.1 (± 15.9) years, 3.5 (± 4.4) years of education and individual income of 1.3 (± 2.4) times the minimum wage. Most subjects were in functional classes III or IV of the New York Heart Association, having signs and symptoms of the congestive form of HF as the most frequent cause of hospitalization. Of all subjects, 75.4% reported clinical follow-ups, although they tended to be irregular. The use of drug therapy occurred in lower ratios than that recommended in the literature. The findings must help to identify patients with higher risk of HC decompensation, and, as such, design and implement specific interventions aiming at reducing re-admittances due to HF. KEY WORDSHeart failure. Nursing care. Hospitalization. RESUMENEste estudio tuvo como objetivo identificar el perfil sociodemográfico y clínico, la historia de hospitalizaciones por Insuficiencia Cardiaca (IC) y el seguimiento (consultas regulares, tratamiento medicamentoso, y, los factores facilitadores y dificultadores del seguimiento) del paciente internado por cuadro de descompensación clínica. Fueron entrevistados 61 pacientes con edad promedio de 58,1(±15,9) años, 3,5 (±4,4) años de estudio y renta individual de 1,3 (±2,4) salarios mínimos. La mayoría de los sujetos se encontraba en la clase funcional III o IV de la New York Heart Asociation, teniendo como causa más frecuente de hospitalización las señales/síntomas de la forma congestiva de la IC; 75,4% de los sujetos relataron acompañamiento clínico, s...

show abstract

Heart failure: preventing disease and death worldwide

et al. 2014

Self Cite

View full text Add to dashboard Cite

Executive Summary Heart failure is a life-threatening disease and addressing it should be considered a global health priority. At present, approximately 26 million people worldwide are living with heart failure. The outlook for such patients is poor, with survival rates worse than those for bowel, breast or prostate cancer. Furthermore, heart failure places great stresses on patients, caregivers and healthcare systems. Demands on healthcare services, in particular, are predicted to increase dramatically over the next decade as patient numbers rise owing to ageing populations, detrimental lifestyle changes and improved survival of those who go on to develop heart failure as the final stage of another disease. It is time to ease the strain on healthcare systems through clear policy initiatives that prioritize heart failure prevention and champion equity of care for all. Despite the burdens that heart failure imposes on society, awareness of the disease is poor. As a result, many premature deaths occur. This is in spite of the fact that most types of heart failure are preventable and that a healthy lifestyle can reduce risk. Even after heart failure has developed, premature deaths could be prevented if people were taught to recognize the symptoms and seek immediate medical attention. Public awareness campaigns focusing on these messages have great potential to improve outcomes for patients with heart failure and ultimately to save lives.

show abstract

Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States

Cited by 60 publications

References 25 publications

É necessário suspender o betabloqueador na insuficiência cardíaca descompensada com baixo débito?

É necessário suspender o betabloqueador na insuficiência cardíaca descompensada com baixo débito?

Características clínicas e psicossociais do paciente com insuficiência cardíaca que interna por descompensação clínica

Heart failure: preventing disease and death worldwide

Contact Info

Product

Resources

About